80. Resistance to thyroid hormone Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drugs : 4 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 4
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Hypothyroidism QOL questionnaire
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Levothyroxine
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Thyrotropin releasing hormone
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
TRH
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Levothyroxine
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
Thyrotropin releasing hormone
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States
TRH
Memorial Sloan Kettering Cancer Center
2021 Phase 1 NCT04868045 United States